Teladoc Health Inc (TDOC)
13.73
-0.01
(-0.07%)
USD |
NYSE |
Apr 24, 16:00
13.66
-0.07
(-0.51%)
After-Hours: 20:00
Teladoc Health Enterprise Value: 2.741B for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 2.741B |
| April 22, 2024 | 2.667B |
| April 19, 2024 | 2.613B |
| April 18, 2024 | 2.647B |
| April 17, 2024 | 2.640B |
| April 16, 2024 | 2.638B |
| April 15, 2024 | 2.709B |
| April 12, 2024 | 2.821B |
| April 11, 2024 | 2.887B |
| April 10, 2024 | 2.870B |
| April 09, 2024 | 2.965B |
| April 08, 2024 | 2.890B |
| April 05, 2024 | 2.868B |
| April 04, 2024 | 2.828B |
| April 03, 2024 | 2.855B |
| April 02, 2024 | 2.841B |
| April 01, 2024 | 2.929B |
| March 28, 2024 | 2.972B |
| March 27, 2024 | 2.966B |
| March 26, 2024 | 2.929B |
| March 25, 2024 | 2.934B |
| March 22, 2024 | 2.921B |
| March 21, 2024 | 2.967B |
| March 20, 2024 | 2.989B |
| March 19, 2024 | 2.926B |
| Date | Value |
|---|---|
| March 18, 2024 | 2.941B |
| March 15, 2024 | 2.941B |
| March 14, 2024 | 2.894B |
| March 13, 2024 | 2.944B |
| March 12, 2024 | 2.982B |
| March 11, 2024 | 3.019B |
| March 08, 2024 | 2.991B |
| March 07, 2024 | 2.979B |
| March 06, 2024 | 2.850B |
| March 05, 2024 | 2.819B |
| March 04, 2024 | 2.875B |
| March 01, 2024 | 2.921B |
| February 29, 2024 | 2.934B |
| February 28, 2024 | 2.936B |
| February 27, 2024 | 2.947B |
| February 26, 2024 | 2.886B |
| February 23, 2024 | 2.837B |
| February 22, 2024 | 2.956B |
| February 21, 2024 | 3.028B |
| February 20, 2024 | 3.838B |
| February 16, 2024 | 3.928B |
| February 15, 2024 | 4.016B |
| February 14, 2024 | 3.858B |
| February 13, 2024 | 3.733B |
| February 12, 2024 | 3.932B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.613B
Minimum
Apr 19 2024
44.90B
Maximum
Feb 08 2021
11.70B
Average
6.184B
Median
Enterprise Value Benchmarks
| Omnicell Inc | 1.397B |
| Phreesia Inc | 1.220B |
| 10x Genomics Inc | 2.897B |
| Biote Corp | 215.29M |
| American Shared Hospital Services | 26.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -28.89M |
| Revenue (Quarterly) | 660.53M |
| Total Expenses (Quarterly) | 690.45M |
| EPS Diluted (Quarterly) | -0.17 |
| Gross Profit Margin (Quarterly) | 70.72% |
| Profit Margin (Quarterly) | -4.37% |
| Earnings Yield | -9.76% |
| Normalized Earnings Yield | -8.270 |